SCHEMBL22490597

SCHEMBL22490597

Cc1nc2ccc(F)c(OCC=O)c2n(C)c1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.38
GLA P06280 3/20 0.38
HPGD P15428 3/20 0.38
KDM4E B2RXH2 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CYP1A2 P05177 13/20 0.36
HSD17B10 Q99714 6/20 0.34
USP2 O75604 6/20 0.34
TSHR P16473 5/20 0.34
MAPK1 P28482 3/20 0.34
CASP1 P29466 3/20 0.34
CASP7 P55210 3/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
CYP2D6 P10635 2/20 0.34
CLK4 Q9HAZ1 2/20 0.34
CYP3A4 P08684 7/20 0.34
CTSL P07711 1/20 0.33
CTSS P25774 1/20 0.33
CTSK P43235 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25493161 0.81 CYP1A2 (0.36) ALDH1A1GLAHPGDKDM4ESMN1; SMN2
SCHEMBL23084964 0.80 CTSL (0.35) ALDH1A1GLAHPGDCYP1A2HSD17B10
SCHEMBL22490612 0.79 CYP1A2 (0.34) ALDH1A1GLAHPGDKDM4ESMN1; SMN2
SCHEMBL21883271 0.78 ALDH1A1 (0.37) ALDH1A1GLAHPGDKDM4ESMN1; SMN2
SCHEMBL22490618 0.75 CTSS (0.40) CTSLCTSSCTSK
SCHEMBL30448719 0.75 CTSS (0.40) CTSLCTSSCTSK
SCHEMBL30448226 0.73 ALDH1A1 (0.41) ALDH1A1GLAHPGDKDM4ESMN1; SMN2
SCHEMBL21820229 0.73 ALDH1A1 (0.41) ALDH1A1GLAHPGDKDM4ESMN1; SMN2
SCHEMBL22490588 0.73 ALDH1A1 (0.41) ALDH1A1GLAHPGDKDM4ESMN1; SMN2
SCHEMBL21820181 0.72 ALDH1A1 (0.36) ALDH1A1GLAHPGDKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111527093-B Antibacterial heterocyclic compounds and synthesis thereof 巴格沃克斯研究有限公司 2023-06-09 CN disclosed
EP-3717490-B1 ANTI-BACTERIAL HETEROCYCLIC COMPOUNDS AND THEIR SYNTHESIS BUGWORKS RES INC (US) 2023-05-24 EP disclosed
EP-3717490-B1 ANTI-BACTERIAL HETEROCYCLIC COMPOUNDS AND THEIR SYNTHESIS BUGWORKS RES INC (US) 2023-05-24 EP disclosed
US-11401277-B2 Anti-bacterial heterocyclic compounds and their synthesis Bugworks Research, Inc. (US) 2022-08-02 US disclosed
US-20210070772-A1 ANTI-BACTERIAL HETEROCYCLIC COMPOUNDS AND THEIR SYNTHESIS Bugworks Research, Inc. 2021-03-11 US disclosed
US-20210070772-A1 ANTI-BACTERIAL HETEROCYCLIC COMPOUNDS AND THEIR SYNTHESIS Bugworks Research, Inc. 2021-03-11 US disclosed
EP-3717490-A1 ANTI-BACTERIAL HETEROCYCLIC COMPOUNDS AND THEIR SYNTHESIS Bugworks Research, Inc. (US) 2020-10-07 EP disclosed
CN-111527093-A Antibacterial heterocyclic compounds and synthesis thereof 巴格沃克斯研究有限公司 2020-08-11 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210070772-A1 ANTI-BACTERIAL HETEROCYCLIC COMPOUNDS AND THEIR SYNTHESIS HLA-B, BAX, REN ALDH1A1 2677/4885GLA 188/4885HPGD 1607/4885
US-11401277-B2 Anti-bacterial heterocyclic compounds and their synthesis HLA-B, BAX, REN ALDH1A1 2677/4885GLA 188/4885HPGD 1607/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.